Analysts Issue Forecasts for Sanuwave Health Q3 Earnings

Key Points

• Northland Capital Markets projects Sanuwave Health to earn $0.08 per share in Q3 2025, with estimates of $0.20 EPS for Q4 2025 and $1.00 EPS for FY2026.
• Sanuwave Health recently reported $0.01 EPS for the prior quarter, exceeding expectations by $0.10, with total revenue of $10.16 million.
• The company's stock received a "Strong-Buy" rating from Northland Capital Markets, with a consensus target price of $55.00 from various analysts.

Sanuwave Health Inc. (NASDAQ:SNWV - Free Report) - Research analysts at Northland Capmk issued their Q3 2025 EPS estimates for Sanuwave Health in a research note issued on Wednesday, September 3rd. Northland Capmk analyst C. Byrnes anticipates that the company will post earnings of $0.08 per share for the quarter. Northland Capmk has a "Strong-Buy" rating on the stock. Northland Capmk also issued estimates for Sanuwave Health's Q4 2025 earnings at $0.20 EPS and FY2026 earnings at $1.00 EPS.

Other equities research analysts have also recently issued reports about the company. Wall Street Zen cut Sanuwave Health from a "strong-buy" rating to a "buy" rating in a research note on Sunday. Northland Securities began coverage on shares of Sanuwave Health in a research note on Wednesday, September 3rd. They set an "outperform" rating and a $55.00 target price on the stock. Finally, Roth Capital boosted their target price on shares of Sanuwave Health from $54.00 to $55.00 and gave the stock a "buy" rating in a research note on Friday, August 22nd. One research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $55.00.

Sanuwave Health Trading Down 4.8%

NASDAQ SNWV traded down $1.75 on Friday, hitting $34.34. 22,413 shares of the company's stock were exchanged, compared to its average volume of 51,027. The business has a 50-day moving average price of $37.61. Sanuwave Health has a 52 week low of $5.63 and a 52 week high of $46.58. The company has a market cap of $294.29 million, a PE ratio of -4.16 and a beta of 1.39.

Sanuwave Health (NASDAQ:SNWV - Get Free Report) last released its earnings results on Friday, August 8th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.10. The business had revenue of $10.16 million for the quarter, compared to the consensus estimate of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Hedge Funds Weigh In On Sanuwave Health

A number of hedge funds have recently bought and sold shares of SNWV. Legal & General Group Plc bought a new position in Sanuwave Health during the second quarter worth $26,000. BNP Paribas Financial Markets bought a new stake in Sanuwave Health in the second quarter worth approximately $46,000. Strategic Investment Solutions Inc. IL bought a new stake in Sanuwave Health in the first quarter worth approximately $47,000. Police & Firemen s Retirement System of New Jersey bought a new stake in Sanuwave Health in the second quarter worth approximately $52,000. Finally, New York State Common Retirement Fund bought a new stake in Sanuwave Health in the second quarter worth approximately $102,000. Institutional investors own 42.53% of the company's stock.

About Sanuwave Health

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.